Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NIMODIPINE for Cerebral vasoconstriction: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 50 adverse event reports in the FDA FAERS database where NIMODIPINE was used for Cerebral vasoconstriction.

Most Reported Side Effects for NIMODIPINE

Side Effect Reports % Deaths Hosp.
Drug ineffective 37 8.9% 4 8
Hypotension 37 8.9% 2 26
Cholestasis 31 7.5% 0 14
Off label use 28 6.7% 0 4
Intentional overdose 26 6.3% 0 26
Cardiogenic shock 25 6.0% 0 25
Toxicity to various agents 25 6.0% 3 21
Renal failure 24 5.8% 0 24
Premature baby 23 5.5% 0 6
Brain injury 22 5.3% 0 22
Cognitive disorder 22 5.3% 0 22
Foetal exposure during pregnancy 22 5.3% 0 5
Lactic acidosis 22 5.3% 0 22
Sinus bradycardia 21 5.1% 0 21
Cerebral ischaemia 20 4.8% 1 19

Other Indications for NIMODIPINE

Product used for unknown indication (131) Subarachnoid haemorrhage (39) Reversible cerebral vasoconstriction syndrome (26) Haemorrhage intracranial (20) Hypertension (16) Headache (13) Intentional overdose (10) Prophylaxis (10) Intracranial pressure increased (7) Vasospasm (6)

Other Drugs Used for Cerebral vasoconstriction

VERAPAMIL (43) NICARDIPINE (23) MILRINONE (14) ATORVASTATIN (11) DANTROLENE (6) NOREPINEPHRINE (6)

Related Pages

NIMODIPINE Full Profile All Cerebral vasoconstriction Drugs NIMODIPINE Demographics NIMODIPINE Timeline